Goldman Sachs CEO: ‘We’ve seen some job data that indicates that there has been some softening’September 10, 2025
Goldman Sachs CEO: ‘We’ve seen some job data that indicates that there has been some softening’September 10, 2025
Signos CEO Sharam Fouladgar-Mercer talks first FDA-approved glucose monitor for weight lossSeptember 10, 2025
Share Facebook Twitter LinkedIn Pinterest Email Signos CEO Sharam Fouladgar-Mercer joins ‘Fast Money’ to talk first FDA-approved glucose monitor for weight loss.
